Ruxolitinib wani nau'i ne na maganin da aka yi niyya na baka wanda ake kira kinase inhibitor kuma ana amfani dashi da yawa don magance cututtuka irin su cututtukan cututtuka, erythroblastosis, da kuma myelofibrosis mai matsakaici da matsakaici, yayin da Ruxolitinib cream wani wakili ne na dermatological wanda ake amfani dashi. kai tsaye a kan fata don magance eczema, vitiligo, atopic dermatitis, da gashi. Ko da yake Ruxolitinib da Ruxolitinib cream sun bambanta da juna, suna da sauƙi a ruɗe saboda suna da irin wannan suna. Changzhou Pharmaceutical Factory (CPF), jagoraRuxolitinib mai sayarwaa kasar Sin, a nan ya yi nazari kan bambance-bambancen da ke tsakaninsu ta fuskar manyan bangarori guda uku don taimaka muku saninsu.
1. Nuni
RuxolitinibFDA ta amince da ita a watan Nuwamba 2011 da Hukumar Turai a watan Agusta 2012 kuma wani nau'i ne na miyagun ƙwayoyi da aka yi niyya tare da takamaiman alamu. Ana amfani da shi don kula da marasa lafiya da ke fama da cututtuka iri uku, ciki har da cututtukan cututtuka na steroid-refractory m graft-versus-host disease, erythroblastosis, da matsakaici-zuwa-high hadarin myelofibrosis (MF). Amma cream na Ruxolitinib yana cikin ci gaba kuma ya kasa tafiya kasuwa, don haka magani ne mai mahimmanci don maganin cutar ciwon huhu da ciwon kai kuma ba shi da wata alamar da aka yarda da ita har yanzu. Duk da haka, nazarin ya nuna kyakkyawan aikin likitancin Ruxolitinib a cikin maganin vitiligo, atopic dermatitis da kuma mai tsanani.
2. Hanyar aikace-aikace
Ruxolitinib shine mai hana kinase na baka wanda ke aiki a matsayin ƙaramin mai hana ƙwayoyin ƙwayoyin furotin JAK1 da JAK2, kuma shine magani na farko da FDA ta amince da shi don magance myelofibrosis. Amma Ruxolitinib cream ne na Topical aikace-aikace cream wanda ya bambanta da gaske daga Ruxolitinib a cikin hanyar da ake amfani da shi.
3. Tasiri
Ruxolitinib yana da bayyanannun sakamako masu illa. Mafi yawan abubuwan da ke haifar da cutar hawan jini da ke hade da amfani da shi shine rage yawan adadin platelet da anemia, kuma mafi yawan abubuwan da ba na jini ba sune petechiae, dizziness, da ciwon kai. Duk da haka, cream na Ruxolitinib har yanzu yana cikin gwaji na asibiti, don haka ba a ƙayyade tasirinsa ba.
Tuntuɓi CPF don samun Ruxolitinib akan farashi mai araha, kuma ku halarci yaƙin neman aikin gwaji na asibiti don samun kirim ɗin Ruxolitinib kyauta.
Lokacin aikawa: Mayu-12-2022